Literature DB >> 416862

Infections in hairy-cell leukemia.

E Bouza, C Burgaleta, D W Golde.   

Abstract

In order to determine the nature of infectious complications in hairy-cell leukemia we studied 20 consecutive patients seen at UCLA and analyzed the available literature. The incidence of serious infection in our series was 40%, and pneumonia and septicemia due to Pseudomonas and E. coli organisms were the leading types of infections. Fungal infections with Cryptococci and Histoplasma organisms were documented, and a single case of Pneumocystis carinii pneumonia was observed. Noninfectious fever occurred in 30% of our patients. There was a clear relationship between fungal disease and corticosteroid therapy, and the overall incidence of infection was correlated with the degree of neutropenia and corticosteroid treatment. No relationship was found between age, duration of disease, or the use of cytotoxic chemotherapy and infectious complications. Of the 13 infectious episodes, 11 occurred in patients prior to splenectomy. Only two episodes were seen in splenectomized patients, both occurring in the immediate postoperative period. We conclude that splenectomy has a beneficial effect in reducing the incidence of infections in hairy-cell leukemia and that corticosteroids should be used cautiously, since they predispose to opportunistic infection in this disease.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 416862

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

Review 1.  Hairy cell leukemia.

Authors:  Ronan Swords; Francis Giles
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

Review 2.  Sweet's syndrome as the presenting symptom of hairy cell leukemia with concomitant infection by Mycobacterium kansasii.

Authors:  C Kramers; J M Raemaekers; H M van Baar; B E de Pauw; A M Horrevorts
Journal:  Ann Hematol       Date:  1992-07       Impact factor: 3.673

3.  Mycotic aneurysm and disseminated Mycobacterium avium-intracellulare infection in a patient with hairy cell leukemia.

Authors:  D C Dugdale; D L Stevens; L L Knight
Journal:  West J Med       Date:  1989-02

4.  Defective autologous and allogeneic mixed lymphocyte reactions in hairy cell leukaemia.

Authors:  R A Knight; C P Worman; J C Cawley
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

5.  Paecilomyces varioti pneumonia complicating hairy cell leukaemia.

Authors:  F M Dharmasena; G S Davies; D Catovsky
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-30

6.  Granulocyte colony-stimulating factor (rh G-CSF) as an adjunct to interferon alpha therapy of neutropenic patients with hairy cell leukemia.

Authors:  C Lorber; A Willfort; L Ohler; U Jäger; I Schwarzinger; K Lechner; K Geissler
Journal:  Ann Hematol       Date:  1993-07       Impact factor: 3.673

Review 7.  Pentostatin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in lymphoproliferative disorders.

Authors:  R N Brogden; E M Sorkin
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

8.  T lymphocyte function in hairy cell leukaemia.

Authors:  L J Sabbe; C J Meijer; J Jansen
Journal:  Clin Exp Immunol       Date:  1980-11       Impact factor: 4.330

Review 9.  The Mycobacterium avium complex.

Authors:  C B Inderlied; C A Kemper; L E Bermudez
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

10.  Histoplasmosis in hairy cell leukemia: case report and review of the literature.

Authors:  E Weeks; C M Jones; V Guinee; R Shallenberger; G A Sarosi; P A Bunnell
Journal:  Ann Hematol       Date:  1992-09       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.